PHSI-BRG
PHSI-BRG
Home
Staff
Theophile Bigirumurame
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Michael Grayling
Shaun Hiu
Dorcas Kareithi
Valentina Mamasoula
John Matthews
Helen Mossop
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Laura Etfer
Aritra Mukherjee
Luke Ouma
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Transforming IMID trials
Projects
Publications
News
Contact
Light
Dark
Automatic
Hall E
Latest
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
5-year patient-reported outcomes of bowel and urinary bother in the CHHiP trial (CRUK/06/016)
Do routine computed tomography scans detect early spinal cord compression in patients with castrate resistant prostate cancer? Implications for the PROMPTS trial
Effect of dose to the penile bbulb on erectile potency (EP) in prostate image-guided radiotherapy (IGRT)
Diffusion-weighted imaging as a treatment response biomarker for evaluating bone metastases in prostate cancer: A pilot study
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
DNA-repair defects and olaparib in metastatic prostate cancer
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
Cite
×